140 related articles for article (PubMed ID: 11255809)
1. Prophylactic actinomycin D for high-risk complete hydatidiform mole.
Limpongsanurak S
J Reprod Med; 2001 Feb; 46(2):110-6. PubMed ID: 11255809
[TBL] [Abstract][Full Text] [Related]
2. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
3. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
[TBL] [Abstract][Full Text] [Related]
4. [The reproductive function following a hydatidiform mole].
Flici O; Tadjerouni A; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(1):67-76. PubMed ID: 6327801
[TBL] [Abstract][Full Text] [Related]
5. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C
J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
Delvoye P; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):147-54. PubMed ID: 8035369
[TBL] [Abstract][Full Text] [Related]
8. Increased gestational age at evacuation of a complete hydatidiform mole: does it correlate with increased risk of requiring chemotherapy?
Seckl MJ; Dhillon T; Dancey G; Foskett M; Paradinas FJ; Rees HC; Sebire N; Vigushin DM; Newlands ES
J Reprod Med; 2004 Jul; 49(7):527-30. PubMed ID: 15305823
[TBL] [Abstract][Full Text] [Related]
9. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
10. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
11. [Risk of malignant changes in hydatidiform mole complicated with pregnancy induced hypertension].
Zhao X; Guan Z
Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):670-2. PubMed ID: 8745493
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles.
Horn LC; Kowalzik J; Bilek K; Richter CE; Einenkel J
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):10-4. PubMed ID: 16530318
[TBL] [Abstract][Full Text] [Related]
13. Guidelines following hydatidiform mole: a reappraisal.
Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
[TBL] [Abstract][Full Text] [Related]
14. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy.
Uberti EM; Fajardo Mdo C; Ferreira SV; Pereira MV; Seger RC; Moreira MA; Torres MD; de Nápoli G; Schmid H
Gynecol Oncol; 2009 Dec; 115(3):476-81. PubMed ID: 19818481
[TBL] [Abstract][Full Text] [Related]
15. Complete hydatidiform mole coexisting with a twin live fetus: clinical course.
Hurteau JA; Roth LM; Schilder JM; Sumners J
Gynecol Oncol; 1997 Jul; 66(1):156-9. PubMed ID: 9234938
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of women with recurrent molar pregnancies.
Lorigan PC; Sharma S; Bright N; Coleman RE; Hancock BW
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):288-92. PubMed ID: 10985882
[TBL] [Abstract][Full Text] [Related]
17. Hydatidiform mole in Kandang Kerbau Hospital--a 5-year review.
Chong CY; Koh CF
Singapore Med J; 1999 Apr; 40(4):265-70. PubMed ID: 10487081
[TBL] [Abstract][Full Text] [Related]
18. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
19. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
Ngan HY; Wong LC
Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
[TBL] [Abstract][Full Text] [Related]
20. Complete molar pregnancy. Clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia.
Felemban AA; Bakri YN; Alkharif HA; Altuwaijri SM; Shalhoub J; Berkowitz RS
J Reprod Med; 1998 Jan; 43(1):11-3. PubMed ID: 9475143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
